Physicians have launched the world’s first mRNA lung cancer vaccine trial, marking a significant advancement in cancer treatment.
BioNTech developed the vaccine BNT116, which targets non-small cell lung cancer (NSCLC) by training the immune system to identify and attack tumor markers.
Conducted across seven countries, including Türkiye, the phase 1 trial involves 130 patients with varying stages of lung cancer and aims to eliminate cancer cells and prevent recurrence.
The trial uses mRNA technology similar to that in COVID-19 vaccines, potentially offering a less toxic alternative to traditional chemotherapy.
Experts view this trial as a groundbreaking step in cancer research, with the first patient in the UK receiving the vaccine recently.
Source : PhilNews24 | August 24, 2024
WORLD’S INITIAL LUNG CANCER VACCINE TRIAL KICKS OFF
You might be interested in
Latest from News
Former DPWH chief Babes Singson and SGV managing partner Rossana Fajardo were appointed commissioners of President
The Zambales provincial government has terminated two major infrastructure projects worth nearly P1 billion after the
The Department of Labor and Employment (DOLE) will roll out P559 million in aid and open
The Armed Forces of the Philippines (AFP) participated in the 3rd Quarter 2025 National Simultaneous Earthquake
US Secretary of State Marco Rubio expressed support for the Philippines in opposing China’s plan to